ClinicaliQ Trial Snapshot
- An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial — Active Not Recruiting • Phase III • Oncology • NCT03844048.
- Venetoclax extension study collecting long-term safety data in patients continuing to benefit from treatment.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies. Conditions: Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia, Cancer Interventions: Venetoclax Lead Sponsor: AbbVie Planned Enrollment: 165 participants